The activity of silver nanoparticles against microalgae of the Prototheca genus

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Christenhusz MJM, Byng JW. The number of known plants species in the world and its annual increase. Phytotaxa 261, 201–217 (2016).
  Google Scholar
• 2 Jagielski T, Lagneau PE. Protothecosis. A pseudofungal infection. J. Mycol. Med. 17, 261–270 (2007). •• A comprehensive review on Prototheca spp. and protothecal infections.
  Google Scholar
• 3 Roesler U, Möller A, Hensel A, Baumann D, Truyen U. Diversity within the current algal species Prototheca zopfii: a proposal for two Prototheca zopfii genotypes and description of a novel species, Prototheca blaschkeae sp. nov. Int. J. Sys. Evol. Microbiol. 56, 1–7 (2006).
  MedlineGoogle Scholar
• 4 Satoh K, Ooe K, Nagayama H, Makimura K. Prototheca cutis sp. nov., a newly discovered pathogen of protothecosis isolated from inflamed human skin. Int. J. Sys. Evol. Microbiol. 60, 1236–1240 (2010).
  Medline CASGoogle Scholar
• 5 Masuda M, Hirose N, Ishikawa T. Prototheca miyajii sp. nov., isolated from a patient with systemic protothecosis. Int. J. Sys. Evol. Microbiol. 66, 1510–1520 (2016).
  Medline CASGoogle Scholar
• 6 Nagatsuka Y, Kiyuna T, Kigawa R, Sano C, Sugiyama J. Prototheca tumulicola sp. nov., a novel achlorophyllous algal species isolated from the stone chamber interior of the Takamatsuzuka Tumulus. Mycoscience 58, 53–59 (2017).
  Google Scholar
• 7 Todd JR, King JW, Oberle A et al. Protothecosis: report of a case with 20 year follow-up, and review of previously published cases. Med. Mycol. 50, 673–689 (2012). • A most recent review of reported cases of human protothecosis.
  Medline CASGoogle Scholar
• 8 Bueno VF, de Mesquita AJ, Neves RB et al. Epidemiological and clinical aspects of the first outbreak of bovine mastitis caused by Prototheca zopfii in Goiás State, Brazil. Mycopathologia 161, 141–145 (2006).
  MedlineGoogle Scholar
• 9 Gao J, Zhang HQ, He JZ et al. Characterization of Prototheca zopfii associated with outbreak of bovine clinical mastitis in herd of Beijing, China. Mycopathologia 173, 275–281 (2012).
  Medline CASGoogle Scholar
• 10 Ricchi M, De Cicco C, Buzzini P et al. First outbreak of bovine mastitis caused by Prototheca blaschkeae. Vet. Microbiol. 162, 997–999 (2013).
  Medline CASGoogle Scholar
• 11 Jagielski T, Lassa H, Ahrholdt J, Malinowski E, Roesler U. Genotyping of bovine Prototheca mastitis isolates from Poland. Vet. Microbiol. 149, 283–287 (2011).
  MedlineGoogle Scholar
• 12 Buzzini P, Turchetti B, Branda E et al. Large-scale screening of the in vitro susceptibility of Prototheca zopfii towards polyene antibiotics. Med. Mycol. 46, 511–514 (2008).
  Medline CASGoogle Scholar
• 13 Jagielski T, Buzzini P, Lassa H et al. Multicentre Etest evaluation of in vitro activity of conventional antifungal drugs against European bovine mastitis Prototheca spp. isolates. J. Antimicrob. Chemother. 67, 1945–1947 (2012). •• A multicenter, cross-national study on susceptibility of Prototheca spp. against antifungal agents.
  Medline CASGoogle Scholar
• 14 Lassa H, Malinowski E. Resistance of yeasts and algae isolated from cow mastitic milk to antimicrobial agents. Bull. Vet. Inst. Pulawy 51, 575–578 (2007).
  Google Scholar
• 15 Tortorano AM, Prigitano A, Dho G, Piccinini R, Daprà V, Viviani MA. In vitro activity of conventional antifungal drugs and natural essences against the yeast-like alga Prototheca. J. Antimicrob. Chemother. 61, 1312–1314 (2008).
  Medline CASGoogle Scholar
• 16 Turchetti B, Pinelli P, Buzzini P et al. In vitro antimycotic activity of some plant extracts towards yeast and yeast-like strains. Phytother. Res. 19, 44–49 (2005).
  Medline CASGoogle Scholar
• 17 Buzzini P, Menichetti S, Pagliuca C, Viglianisi C, Branda E, Turchetti B. Antimycotic activity of 4-thioisosteres of flavonoids towards yeast and yeast-like microorganisms. Bioorg. Med. Chem. Lett. 18, 3731–3733 (2008).
  Medline CASGoogle Scholar
• 18 Tomasinsig L, Skerlavaj B, Scarsini M et al. Comparative activity and mechanism of action of three types of bovine antimicrobial peptides against pathogenic Prototheca spp. J. Pept. Sci. 18, 105–113 (2012).
  Medline CASGoogle Scholar
• 19 Cunha LT, Pugine SMP, Silva MRM, Costa EJ, De Melo MP. Microbicidal action of indole-3-acetic acid combined with horseradish peroxidase on Prototheca zopfii from bovine mastitis. Mycopathologia 169, 99–105 (2010).
  Medline CASGoogle Scholar
• 20 Grzesiak B, Głowacka A, Krukowski H, Lisowski A, Lassa H, Sienkiewicz M. The in vitro efficacy of essential oils and antifungal drugs against Prototheca zopfii. Mycopathologia 181, 609–615 (2016).
  Medline CASGoogle Scholar
• 21 Bouari C, Bolfa P, Borza G, Nadăş G, Cătoi C, Fiţ N. Antimicrobial activity of Mentha piperita and Saturenja hortensis in a murine model of cutaneous protothecosis. J. Mycol. Méd. 24, 34–43 (2014).
  Medline CASGoogle Scholar
• 22 Alves AC, Capra E, Morandi S et al. In vitro algicidal effect of guanidine on Prototheca zopfii genotype 2 strains isolated from clinical and subclinical bovine mastitis. Lett. Appl. Microbiol. 64, 419–423 (2017).
  Medline CASGoogle Scholar
• 23 Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol. Pharm. 6, 1388–1401 (2009).
  Medline CASGoogle Scholar
• 24 Rigo C, Ferroni L, Tocco I et al. Active silver nanoparticles for wound healing. Int. J. Mol. Sci. 14, 4817–4840 (2013).
  Medline CASGoogle Scholar
• 25 Fayaz AM, Balaji K, Girilal M, Kalaichelvan PT, Venkatesan R. Mycobased synthesis of silver nanoparticles and their incorporation into sodium alginate films for vegetable and fruit preservation. J. Agric. Food Chem. 57, 6246–6252 (2009).
  MedlineGoogle Scholar
• 26 Li Q, Mahendra S, Lyon DY et al. Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. Water Res. 42, 4591–4602 (2008).
  Medline CASGoogle Scholar
• 27 Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 28, 580–588 (2010).
  Medline CASGoogle Scholar
• 28 Vance ME, Kuiken T, Vejerano EP et al. Nanotechnology in the real world: redeveloping the nanomaterial consumer products inventory. Beilstein J. Nanotechnol. 6, 1769–1780 (2015).
  Medline CASGoogle Scholar
• 29 Ingle A, Gade A, Pierrat S, Sonnichsen C, Rai M. Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria. Curr. Nanothechnol. 4, 141–144 (2008).
  CASGoogle Scholar
• 30 Paredes D, Ortiz C, Torres R. Synthesis, characterization, and evaluation of antibacterial effect of Ag nanoparticles against Escherichia coli O157:H7 and methicillin-resistant Staphylococcus aureus (MRSA). Int. J. Nanomedicine 9, 1717–1729 (2014).
  MedlineGoogle Scholar
• 31 Martinez F, Olive PL, Banuelos A et al. Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomedicine 6, 681–688 (2010). • A comprehensive review on antimicrobial action and cytotoxicity of silver nanoparticles.
  MedlineGoogle Scholar
• 32 Kim KJ, Sung WS, Moon SK, Choi JS, Kim JG, Lee DG. Antifungal effect of silver nanoparticles on dermatophytes. J. Microbiol. Biotechnol. 18, 1482–1484 (2008).
  Medline CASGoogle Scholar
• 33 Panácek A, Kolár M, Vecerová R et al. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 30, 6333–6340 (2009).
  Medline CASGoogle Scholar
• 34 Tile VA, Bholay AD. Biosynthesis of silver nanoparticles and its antifungal activities. J. Environ. Res. Develop. 7, 338–345 (2012).
  Google Scholar
• 35 Lu L, Sun RW, Chen R et al. Silver nanoparticles inhibit hepatitis B virus replication. Antivir. Ther. 13, 253–262 (2008).
  Medline CASGoogle Scholar
• 36 Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnology 8, 1 (2010).
  MedlineGoogle Scholar
• 37 Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug. Chem. 20, 1497–1502 (2009).
  Medline CASGoogle Scholar
• 38 Murugan K, Samidoss CM, Panneerselvam C et al. Seaweed-synthesized silver nanoparticles: an eco-friendly tool in the fight against Plasmodium falciparum and its vector Anopheles stephensi? Parasitol. Res. 114, 4087–4097 (2015).
  MedlineGoogle Scholar
• 39 Rajakumar G, Rahuman AA. Acaricidal activity of aqueous extract and synthesized silver nanoparticles from Manilkara zapota against Rhipicephalus (Boophilus) microplus. Res. Vet. Sci. 93, 303–309 (2011).
  MedlineGoogle Scholar
• 40 Veerakumar K, Govindarajan M, Rajeswary M, Muthukumaran U. Mosquito larvicidal properties of silver nanoparticles synthesized using Heliotropium indicum (Boraginaceae) against Aedes aegypti, Anopheles stephensi, and Culex quinquefasciatus (Diptera: Culicidae). Parasitol. Res. 113, 2363–2373 (2014).
  MedlineGoogle Scholar
• 41 Ong C, Lim JZ, Ng CT, Li JJ, Yung LY, Bay BH. Silver nanoparticles in cancer: therapeutic efficacy and toxicity. Curr. Med. Chem. 20, 772–781 (2013).
  Medline CASGoogle Scholar
• 42 Chwalibog A, Sawosz E, Hotowy A et al. Visualization of interaction between inorganic nanoparticles and bacteria or fungi. Int. J. Nanomed. 5, 1085–1094 (2010).
  MedlineGoogle Scholar
• 43 Zavizion B, van Duffelen M, Schaeffer W, Politis I. Establishment and characterization of a bovine mammary epithelial cell line with unique properties. In vitro Cell Dev. Biol. Anim. 32, 138–148 (1996).
  Medline CASGoogle Scholar
• 44 CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard – (3rd Edition). CLSI document M27–A3. Clinical and Laboratory Standards Institute, PA, USA (2008).
  Google Scholar
• 45 Jagielski T, Bakuła Z, Di Mauro S et al. A comparative study of the in vitro activity of iodopropynyl butylcarbamate and amphotericin B against Prototheca spp. isolates from European dairy herds. J. Dairy Sci. 100(9), 7435–7445 (2017).
  Medline CASGoogle Scholar
• 46 Luft JH. Improvements in epoxy resin embedding methods. J. Biophys. Biochem. Cytol. 9, 409–414 (1961).
  Medline CASGoogle Scholar
• 47 Reynollds ES. The use of lead citrate at high pH as electron-opaque stain for electron microscopy. J. Cell. Biol. 17, 208–213 (1983).
  Google Scholar
• 48 Alexander JW. History of the medical use of silver. Surg. Infect. 10, 289–292 (2009).
  MedlineGoogle Scholar
• 49 Zhang XF, Liu ZG, Shen W, Gurunathan S. Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Int. J. Mol. Sci. 17, E1534 (2016).
  MedlineGoogle Scholar
• 50 Sweet MJ, Singleton I. Silver nanoparticles: a microbial perspective. Adv. Appl. Microbiol. 77, 115–133 (2011).
  Medline CASGoogle Scholar
• 51 Rai M, Kon K, Ingle A, Duran N, Galdiero S, Galdiero M. Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects. Appl. Microbiol. Biotechnol. 98, 1951–1961 (2014).
  Medline CASGoogle Scholar
• 52 Markowska K, Grudniak AM, Wolska KI. Silver nanoparticles as an alternative strategy against bacterial biofilms. Acta Biochim. Pol. 60, 523–530 (2013).
  MedlineGoogle Scholar
• 53 Oukarroum A, Bras S, Perreault F, Popovic R. Inhibitory effects of silver nanoparticles in two green algae, Chlorella vulgaris and Dunaliella tertiolecta. Ecotoxicol. Environ. Saf. 78, 80–85 (2012).
  Medline CASGoogle Scholar
• 54 Książyk M, Asztemborska M, Stęborowski R, Bystrzejewska-Piotrowska G. Toxic effect of silver and platinum nanoparticles toward the freshwater microalga Pseudokirchneriella subcapitata. Bull. Environ. Contam. Toxicol. 94, 554–558 (2015).
  Medline CASGoogle Scholar
• 55 Zouzelka R, Cihakova P, Rihova Ambrozova J, Rathousky J. Combined biocidal action of silver nanoparticles and ions against Chlorococcales (Scenedesmus quadricauda, Chlorella vulgaris) and filamentous algae (Klebsormidium sp.). Environ. Sci. Pollut. Res. Int. 23, 8317–8326 (2016).
  Medline CASGoogle Scholar
• 56 de Camargo Z, Fischman O. Prototheca stagnora, an encapsulated organism. Sabouraudia 17, 197–200 (1979).
  Medline CASGoogle Scholar
• 57 Sobukawa H, Kano R, Ito T et al. In vitro susceptibility of Prototheca zopfii genotypes 1 and 2. Med. Mycol. 49, 222–224 (2011).
  Medline CASGoogle Scholar
• 58 Morones JR, Elechiguerra JL, Camacho A et al. The bactericidal effect of silver nanoparticles. Nanotechnology 16, 2346–2353 (2005).
  Medline CASGoogle Scholar
• 59 Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine 6, 103–109 (2010).
  Medline CASGoogle Scholar
• 60 Xu Y, Gao C, Li X, He Y, Zhou L, Pang G. In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi. J. Ocul. Pharmacol. Ther. 29, 270–274 (2013).
  MedlineGoogle Scholar
• 61 Gambardella C, Costa E, Piazza V et al. Effect of silver nanoparticles on marine organisms belonging to different trophic levels. Mar. Environ. Res. 111, 41–49 (2015).
  Medline CASGoogle Scholar
• 62 Navarro E, Piccapietra F, Wagner B et al. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ. Sci. Technol. 42, 8959–8964 (2008).
  Medline CASGoogle Scholar
• 63 Conte MV, Pore RS. Taxonomic implications of Prototheca and Chlorella cell wall polysaccharide characterization. Arch. Mikrobiol. 92, 227–233 (1973).
  Medline CASGoogle Scholar
• 64 Jiravova J, Tomankova KB, Harvanova M et al. The effect of silver nanoparticles and silver ions on mammalian and plant cells in vitro. Food Chem. Toxicol. 96, 50–61 (2016).
  Medline CASGoogle Scholar
• 65 Wang S, Lv J, Ma J, Zhang S. Cellular internalization and intracellular biotransformation of silver nanoparticles in Chlamydomonas reinhardtii. Nanotoxicology 10, 1129–1135 (2016).
  MedlineGoogle Scholar
• 66 Melville PA, Benites NR, Sinhorini IL, Costa EO. Susceptibility and features of the ultrastructure of Prototheca zopfii following exposure to copper sulphate, silver nitrate and chlorexidine. Mycopathologia 156, 1–7 (2002).
  Medline CASGoogle Scholar